MedTrace Logo

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

NCT07108660 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17800

Last updated 2025-08-15

No results posted yet for this study

Summary

Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with just-in-time clinical education and reinforcement of existing best practices recommendations based on the output of a possible Central Line Associated Blood Stream Infection (CLABSI) Machine Learning (ML) prediction model.

The objective is to determine whether providing this model to Infection Preventionists will decrease the CLABSI rates versus routine clinical practice.

Conditions

  • Central Line Associated Blood Stream Infections (CLABSI)

Interventions

BEHAVIORAL

Infection Preventionist Led Best Practices Reminders

Infection preventionists at each study hospital review a dashboard on a daily basis that contains predictions for the infection preventionist's hospital. If a patient is predicted to have a possible CLABSI by the ML model, the infection preventionist reviews the case and recommends next steps to the care team based on Providence's CLABSI prevention best-practices bundle, which include reviewing the line for necessity and recommending alternate IV access when appropriate. If line-removal isn't possible, the infection preventionist collaborates with the direct care team to ensure that the line maintenance best practices are observed, including maintaining a clean, dry and intact dressing and using daily chlorhexidine baths.

Sponsors & Collaborators

  • Providence Health & Services

    collaborator OTHER

  • Swedish Medical Center

    lead OTHER

Principal Investigators

  • Chris Dale, MD, MPH · Swedish Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-11-30
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07108660 on ClinicalTrials.gov